Clinical director
Dr. Nathan Rhee, MD
Director, Structural Heart · Heart & Vascular Institute
Dr. Rhee runs the structural heart program at Aster. He has performed more than 2,000 TAVR, MitraClip, and LAAC procedures. His research focuses on quality outcomes in structural heart interventions and on expanding access to TAVR in underserved populations.
Focus areas
TAVR and transcatheter aortic valve therapiesMitral valve interventionsLeft atrial appendage closureHigh-risk PCI
Education
MD, Stanford University School of Medicine
Residency, Internal Medicine, UCSF
Fellowships, Interventional Cardiology and Structural Heart, Columbia Presbyterian
Research
Co-Investigator, PARTNER 3 low-risk TAVR trial
Author, 2025 JACC review on structural heart quality metrics